PharMerica (PMC) Raises FY14 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Goldman Sachs Starts PharMerica (PMC) at Neutral
September 11, 2014 6:52 AM EDTGoldman Sachs initiated coverage on PharMerica (NYSE: PMC) with a Neutral rating and a price target of $29.00.
Analyst Stephan Stewart said, "We are encouraged by PMCs efforts in managing through the loss of its top two clients (15-20% of sales) with (1) organic underlying... More
